FA
REGN icon

Fermata Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Fermata Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$227K Buy
+300
New +$227K 0.04% 256
2025
Q1 		– Sell
-290
Closed -$207K – 299
2024
Q4 		$207K Buy
+290
New +$243K 0.04% 254

Other funds holding REGN

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Fermata Advisors's REGN Position: Q3 2026 in Review

Fermata Advisors opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 300 shares worth $227K. The stake represents 0.04% of the portfolio and ranks #256 among its holdings. This is a return to the name: Fermata Advisors previously reported a position in REGN as recently as Q4 2024.

Fermata Advisors first reported a position in REGN in Q4 2024 and has held it in 2 quarters since. 161 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Fermata Advisors held 300 shares of Regeneron Pharmaceuticals worth $227K as of Q3 2026.
  • Regeneron Pharmaceuticals was a new Fermata Advisors position in Q3 2026.
  • Regeneron Pharmaceuticals made up 0.04% of Fermata Advisors's portfolio in Q3 2026, its #256 holding.
  • Fermata Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 2 quarters since.
  • 161 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Fermata Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.